Sector portfolio · VC firm · Germany
Wellington Partners' Biotech portfolio
Wellington Partners has backed 18 Biotech startups in rounds we track, $1.5B between them, shown by the stage each has reached. The best-funded is Egenesis.
Wellington Partners's whole portfolioWellington Partners's profile
Funding by segment
- Stage not reported$632M6
- Series A$202M6
- Series C and later$483M4
- Series B$200M2
Where they are based
- Germany8$504M
- United States5$673M
- Denmark2$84M
- Austria1$56M
- Belgium1$103M
- France1$97M
Germany
United States
Denmark
Austria
Belgium
FranceFounded
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M5
- $50M to $250M9
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
13 of 18 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- Germany8
- United States5
- Denmark2
- Austria1
- Belgium1
- France1
Startups by country, 6 countries in all.
Segment by segment
Stage not reported
6 startups · $632M raised
AMBOSSAMBOSS is a global medical technology company based in Berlin, founded in 2012 by physicians.Germany$292M
Beren TherapeuticsBeren Therapeutics P.B.C.United States$165M- MMinervaxDenmark$62M
- TThemisAustria$56M
HepaRegeniXHepaRegeniX is developing drugs for treating acute and chronic liver diseases.Germany$34M
sphingotecSphingoTec is a German diagnostics company based in Hennigsdorf, near Berlin.Germany$23M
Series A
6 startups · $202M raised
IconOVir BioIconOVir Bio is a biotechnology company based in San Diego, California, founded in 2018.United States$77M
SciRhomSciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016.Germany$68M
STipe TherapeuticsSTipe is a biotechnology company that develops therapies to induce innate immune system for the treatment of cancer.Denmark$22M- RRigontecGermany$17M
- MPMiddle Peak MedicalMiddle Peak Medical develops and commercializes a novel technology to treat mitral valve disease.United States$12M
NEUWAY PharmaNEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseasesGermany$7.2M
Series C and later
4 startups · $483M raised
- EeGenesisUnited States$329M
Carisma TherapeuticsCarisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.United States$90M
ImmaticsImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors withGermany$58M
Sphingotec GmbHSphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.Germany$5.5M
Series B
2 startups · $200M raised
Confo TherapeuticsConfo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.Belgium$103M
ImCheck TherapeuticsImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.France$97M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Wellington Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Wellington Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.